tiprankstipranks
Springworks Therapeutics (SWTX)
NASDAQ:SWTX
US Market

Springworks Therapeutics (SWTX) Income Statement

Compare
393 Followers

Springworks Therapeutics Income Statement

Last quarter (Q3 2024), Springworks Therapeutics's total revenue was $49.30M, an increase of 782.58% from the same quarter last year. In Q3, Springworks Therapeutics's net income was $-53.53M. See Springworks Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 5.45M$ 6.15M$ 0.00$ 35.00M$ 0.00
Gross Profit
$ 5.03M$ 4.25M$ -490.00K$ 34.65M$ -192.00K
Operating Expenses
$ 348.04M$ 280.67M$ 173.47M$ 81.32M$ 59.24M
Depreciation and Amortization
$ 1.67M$ 1.90M$ 490.00K$ 349.00K$ 192.00K
EBITDA
$ -341.35M$ -280.67M$ -172.98M$ -45.98M$ -59.05M
Operating Income
$ -343.01M$ -280.67M$ -173.47M$ -46.32M$ -59.24M
Other Income/Expenses
$ 17.91M$ 3.26M$ -442.00K$ 750.00K$ 933.00K
Pretax Income
$ -325.10M$ -277.42M$ -173.91M$ -45.57M$ -58.31M
Net Income
$ -325.10M$ -274.16M$ -173.21M$ -44.24M$ -54.76M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -5.15$ -5.14$ -3.57$ -1.02$ -1.27
Diluted EPS
$ -5.15$ -5.14$ -3.57$ -1.02$ -1.27
Weighted Average Shares Outstanding
63.12M 53.29M 48.50M 43.30M 43.01M
Weighted Average Shares Outstanding (Diluted)
63.12M 53.29M 48.50M 43.30M 43.01M
Currency in USD

Springworks Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis